A game-changing HIV drug was the biggest story of 2024
In what Science called the 'breakthrough of the year', researchers revealed in June that a twice-yearly drug called lenacapavir reduced HIV infections in a trial in Africa to zero—an astonishing 100% efficacy, and the closest thing to a vaccine in four decades of research. buff.ly/3P2zrt7
#ShareGoodNewsToo
In what Science called the 'breakthrough of the year', researchers revealed in June that a twice-yearly drug called lenacapavir reduced HIV infections in a trial in Africa to zero—an astonishing 100% efficacy, and the closest thing to a vaccine in four decades of research. buff.ly/3P2zrt7
#ShareGoodNewsToo
‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries
Gilead Sciences announces deal to manufacture generic versions of lenacapavir, but critics say it excludes many countries where incidence is highestKat Lay (The Guardian)